CCLEAREX.MARKET
Join free
Guggenheim raises Vera Therapeutics stock price target on FDA approval
Market IntelligencePublic

Guggenheim raises Vera Therapeutics stock price target on FDA approval

Investing.com·July 8, 2026·1 min read
Guggenheim raises Vera Therapeutics stock price target on FDA approval
Read full article on Investing.com

Share this article

Follow broker incidents, regulatory actions & market intelligence

Stay ahead with CLEAREX.MARKET

View all intelligence →